Screener
AngioDynamics ANGO EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from AngioDynamics’s reported figures.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026. Open the filing →
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
FAQ
- What is AngioDynamics's EBITDA?
- AngioDynamics (ANGO) reported EBITDA of -$4.6M in Q1 2026.
- How has AngioDynamics's EBITDA changed year-over-year?
- AngioDynamics's EBITDA decreased by 10317.8% year-over-year, from $45K to -$4.6M.
- What is the long-term trend for AngioDynamics's EBITDA?
- Over 4 years (2022 to 2026), AngioDynamics's EBITDA has grown at a 109.7% compound annual growth rate (CAGR), from $878K to -$16.97M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about AngioDynamics's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude